Back to Selection     Print       Date : 28 Feb 2026
Fund Summary
UTI Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Jun-99
Corpus(Cr.) 1107.0 Latest NAV 276.6485 As on 13-03-2026
Equity(%) 98.21 52 Week High 299.714
Debt(%) 1.79 52 Week Low 252.184
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.27
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kamal Gada
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 30.25%
Top 10 Holdings 47.24%
Top 25 Holdings 79.99%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 75.25
Healthcare 22.96
Cash 1.78
Others 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.12
PE Ratio 37.83
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 9.42
AFebta Pharma Limited 7.04
Lupin Limited 5.79
Glenmark Pharmaceuticals Limited 4.25
Apollo Hospitals Enterprise Limited 3.75
Gland Pharma Limited 3.54
DIVI LABORATORIES LTD. 3.52
Dr Reddys Laboratories Limited 3.48
Alkem Laboratories Limited 3.47
Fortis Health Care Ltd 2.98
Max Healthcare Institute Limited 2.85
Cohance Lifesciences Limited 2.66
Aurobindo Pharma Limited 2.66
Caplin Point Laboratories Limited 2.23
Procter & Gamble Health Limited 2.21
Sudeep Pharma Limited 2.19
IPCA Laboratories Limited 2.17
Sequent Scientific Limited 2.11
Sai Life Sciences Limited 2.07
EQ- JUPITER LIFE LINE HOSPITALS LTD 2.06
EQ- GLOBAL HEALTH LTD. 2.02
Aster DM Healthcare Limited 1.94
Anthem Biosciences Limited 1.91
Eris Lifesciences Limited 1.84
Cipla Limited 1.83

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.96% -3.39% -6.34% 8.27%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-9.09% -10.95% -7.41% 4.52%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
1.59% -0.55% -0.24% 12.34%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
13.13% 25.29% 14.94% 12.14%
 
 
3.75% 12.21% 10.46% 13.37%
 
 
12.38% 26.10% 15.92% 9.87%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
UTI Healthcare Fund (G) 15.79% 1.2243 10.4218% 43.8430 0.1614
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
UTI Healthcare Fund (G) 13.6148% 0.0002 0.3173 13.8462 0.9050
 
Back to Selection